Brief: Herantis Pharma Appoints Frans Wuite As Interim CEO
20/01/2022 14:35
Jan 20 (Reuters) - Herantis Pharma Oyj HRTIS.HE :
* HAS APPOINTED FRANS WUITE, MD, MBA, AS INTERIM CEO OF COMPANY, EFFECTIVE IMMEDIATELY
* A SEARCH FOR A PERMANENT CEO WILL BE LAUNCHED
* CURRENT CEO, DR. CRAIG COOK, LEAVES COMPANY FOLLOWING BOARD OF DIRECTORS' DECISION
* BOARD DECIDED TO FOCUS MAJORITY OF CO'S DEVELOPMENT EFFORTS TO ADVANCE HER-096, MOLECULE
SYNTHETIC PEPTIDOMIMETIC OF CEREBRAL DOPAMINERGIC NEUROTROPHIC FACTOR OR CDNF
* COMPANY EXPECTS FILING FOR REGULATORY APPROVAL IN Q4 2022 TO START A FIRST-IN-MAN CLINICAL
STUDY
OF HER-096
Source text for Eikon: ID:nWkr84Yhxd
Further company coverage: HRTIS.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))